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Ig genes encode antibodies whose V regions 
contain the antigen-binding site and whose C 
regions mediate eff  ector functions. During the 
immune response, somatic hypermutation 
(SHM) generates point mutations at very high 
frequencies in Ig V regions of centroblasts (1) in 
germinal centers (GCs) (2). SHM is initiated by 
activation-induced cytidine deaminase (AID) 
(3), which deaminates deoxycytidines (dCs) in 
single-stranded DNA (ssDNA) and converts 
them to deoxyuridine (4–6). Deoxyuridine is 
subsequently processed by replication, uracil-
N-glycosylase and base excision repair, error-
prone polymerases, mismatch repair, and other 
proteins to produce mutations at a rate of 
 10−3 mutations per bp, per generation, i.e., 
106 times higher than the rate of mutation of 
housekeeping genes (7–9). This extraordinary 
rate of mutation is focused on the expressed 
variable Ig regions and, to a lesser extent, to 
some non-Ig genes (10–13). Although the loss 
of AID results in immunodefi  ciency (14), the 
mistargeting of AID-induced mutation is 
thought to be a cause of many B cell lympho-
mas (10, 15). The mechanism responsible for 
targeting SHM to certain DNA regions and 
not to others is largely unknown (9, 16).
In addition to SHM, AID also mediates 
class-switch recombination (CSR) (3) by gen-
erating mutations and triggering recombina-
tion and deletion at switch regions (17). As a 
result of CSR, the V region rearranges to one 
of the downstream C regions that encode 
different effector functions. The transcribed 
strands of mammalian switch recombination 
sequences are C rich, so that their transcription 
results in the formation of R loops in which 
the nascent G-rich RNA transcript remains 
stably bound to the template strand, rendering 
the nontemplate strand single stranded (5, 18). 
AID deaminates the single-stranded, displaced 
nontemplate strand of R loops in vitro, and R 
loops may exist in vivo (5, 18). G quartets can 
form in switch recombination sequences (19) 
and bind mismatch-repair proteins that partici-
pate in the CSR reaction (20). R loops do 
not form in GC-poor switch recombination 
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sequences, such as Xenopus laevis switch regions, where AID 
was found to be targeted to C’s in AGCT motifs (21). Simi-
larly, by virtue of their primary sequence, V regions are not 
predicted to form stable R loops. Experimental evidence that 
ssDNA is enriched in V regions in vivo has been lacking, and 
the mechanisms responsible for generating ssDNA and mak-
ing it accessible to AID in some regions of highly transcribed 
genes but not in others have yet to be established.
In vitro, AID targets dCs on ssDNA (4, 5, 19, 22), 
whereas in Escherichia coli, AID acts on dCs in the nontem-
plate strand (6) or on both strands (23) of transcribed DNA. 
However, both DNA strands in a transcription bubble were 
shown to be deaminated by AID either in DNA transcribed 
by bacterial RNA polymerase (24) or in T7 polymerase–
  transcribed plasmids that are either supercoiled (25) or con-
tain particular primary sequences (26). Replication protein A, 
an ssDNA binding protein, associates with AID and enhances 
its ability to deaminate dCs in T7-transcribed DNA in vitro 
(27). In vivo, transcription is necessary for SHM (28), and 
cis-acting elements that activate transcription of Ig loci also 
up-regulate SHM (29). Histone modifi  cations such as acety-
lation and phosphorylation were shown to be enriched in 
DNA regions targeted by SHM and CSR (30–34), but it is 
not clear if changes in chromatin structure are responsible for 
selective targeting of AID (16).
As described above, the requirement of ssDNA for AID 
targeting has been established using in vitro assays and 
  hypothesized to be made accessible in transcription bubbles 
in vivo based on the observation that SHM and CSR require 
the target genes to be highly transcribed (4–6). However, in 
B cells not all highly transcribed regions of DNA undergo 
AID-induced mutation (35). In this study, we sought to 
  determine whether regions targeted for SHM are enriched in 
ssDNA. To do this, we established a strategy that enabled us 
to search for ssDNA in nuclei in the context of cross-linked 
chromatin. We did not fi  nd R loops in hypermutating V 
  regions. However, we did fi  nd that ssDNA–protein com-
plexes that depended on transcription were enriched in the 
V region compared with the C region, and these ssDNA–  protein 
complexes were found in other regions that undergo SHM.
RESULTS
Detection of ssDNA in chromatinized substrates
In an eff  ort to fi  nd out whether ssDNA is enriched in vivo in 
regions that undergo SHM in B cells, we used sodium bisul-
fi  te, which, like AID, deaminates dCs in ssDNA to form 
  deoxyuridine (36). After PCR amplifi  cation and sequencing 
of bisulfi  te-treated DNA, clones derived from amplifi  cation 
of either the nontemplate (upper, nontranscribed) or the 
template (lower, transcribed) strand reveal the location and 
strand of single-stranded dCs. Thus, C to T conversions indicate 
single-stranded dCs on the upper strand, whereas G to A 
conversions on the lower strand indicate single-stranded 
dCs (Fig. S1, available at http://www.jem.org/cgi/content/
full/jem.20062032/DC1). Bisulfi  te treatment of deprotein-
ized genomic DNA has been used previously to detect the 
ssDNA in R loops in switch regions from mouse B lympho-
cytes undergoing CSR (18) and in ssDNA in plasmid 
  substrates (26). A similar procedure as the one used to detect 
R loops (reference 18 and outlined in Fig. 1 A, left, Deprot-
einized DNA) was used to search for single-stranded dCs 
in the functional heavy chain V region of Ramos Burkitt’s 
lymphoma cells that constitutively undergo SHM at a high 
Figure 1.  A method to detect ssDNA in the context of chromatin. 
(A) Two assays were used to detect ssDNA, one using purifi  ed genomic 
DNA (Deproteinized DNA) (reference 18) and another using DNA in fi  xed 
nuclei (Chromatinized DNA). Both kinds of substrates were treated with 
bisulfi  te, amplifi  ed, cloned, and sequenced as described in Materials and 
methods. (B–D) Frequency of C to T conversions (indicative of ssDNA on 
the noncoding strand) and G to A conversions (indicating ssDNA on the 
template strand) was measured for untreated DNA (B), deproteinized DNA 
(C), and chromatinized DNA (D) treated with bisulfi  te in the IgH V region 
of Ramos cells (depicted above the diagrams). L indicates the leader 
sequence. Position 273 is a hotspot for G to A mutations. (E) Examples of 
ssDNA patches on the coding and noncoding strands. Asterisks indicate 
bases that have been converted by bisulfi  te. Because the length of these 
patches cannot be determined exactly, the minimum size is shown as 
boxes, whereas the maximum size is shown as a horizontal line. (F) The 
frequency of ssDNA patches was calculated for IgH V region in chromati-
nized DNA from Ramos 7 cells untreated (control) or pretreated with 
proteinase K. Numbers above the bar graphs indicate p-values calculated 
using the Chi-squared test. The results are representative of three 
experiments. Sample sizes are indicated in Table S2.JEM VOL. 204, January 22, 2007  183
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frequency of  10−3 (Table I) (37, 38). As seen in Fig. 1 C, the 
V region in the bisulfi  te-treated, deproteinized genomic DNA 
had a similar low frequency of single-stranded dCs as the 
nonbisulfi  te-treated DNA (Fig. 1 B), in which C to T and G to 
A conversions were due to preexisting mutations or PCR errors.
Unlike mammalian switch regions, V and other regions 
that undergo SHM are not GC rich and thus are unlikely to 
form stable R loops. It is, however, possible that ssDNA 
forms in V regions as part of DNA–protein complexes in 
which the DNA strands are prevented from annealing. In this 
case, bisulfi  te would fail to detect ssDNA in assays in which 
DNA is deproteinized, as in the bisulfi  te assay that has been 
used to detect R loops in switch regions (18). To circumvent 
this potential problem, we devised an assay to detect ssDNA 
in the context of chromatin (Fig. 1 A, Chromatinized DNA). 
In this assay, cells were fi  xed with formaldehyde under con-
ditions that preserved the binding of proteins to DNA, as in 
the chromatin immunoprecipitation assay (39), and nuclei 
were isolated and treated with bisulfi  te. The single-stranded 
status of a particular region was then assessed after PCR 
  amplifi  cation, cloning, and sequencing. This assay is able to 
detect single-stranded regions at the single cell level and in a 
strand-specifi  c manner (Fig. S1). We validated this assay by 
showing that it could detect R loops in situ in the GC-rich 
switch regions of mouse B lymphocytes undergoing CSR, 
and that these R loops were similar to the ones identifi  ed by 
others using deproteinized genomic DNA (Fig. S2, available 
at http://www.jem.org/cgi/content/full/jem.20062032/DC1) 
(18). This not only establishes the validity of the assay, but 
also shows that R loops do exist in the cross-linked chromatin 
in the nuclei of switching B cells.
Bisulfi  te was then used to examine the V regions of the 
cross-linked nuclei of constitutively mutating Ramos cells. 
As shown in Fig. 1 D, this revealed a considerable number of 
bisulfi  te-accessible dCs in chromatinized DNA in this V 
  region. As a control for the overall effi   ciency of the bisulfi  te 
reaction, we used preboiled genomic DNA treated with bisul-
fi  te and found that typically  90% of dCs were converted to 
deoxyuridine (not depicted).
Unlike bisulfi  te-accessible dCs present in deproteinized 
DNA (Fig. 1 C), many of the single-stranded dCs found 
on chromatinized DNA were present in patches in which 
three or more single-stranded dCs were clustered together. 
As shown in the examples in Fig. 1 E, these patches often 
contained consecutive bisulfi  te-accessible dCs separated by 
other bases whose single-stranded status cannot be detected 
by this assay. Similar protein-associated patches of ssDNA 
were detected in the heavy and light chain V regions of 
the BL2 Burkitt’s lymphoma cell line and in the V regions 
of light chain of Ramos, as well as in the V regions of other 
human cell lines (Fig. S3, available at http://www.jem.org/
cgi/content/full/jem.20062032/DC1).
Our inability to detect ssDNA in deproteinized genomic 
DNA (Fig. 1 C) and the presence of ssDNA in chromatinized 
substrates (Fig. 1 D) implies that proteins might be needed for 
the formation of ssDNA. We therefore pretreated fi  xed 
  Ramos cell nuclei with proteinase K and found that this 
treatment signifi  cantly diminished the frequency of ssDNA 
patches detected in the V region (Fig. 1 F). This fi  nding indi-
cates that proteins are needed to prevent the DNA strands 
from annealing and suggests that protein–DNA structures are 
required to maintain these patches of ssDNA.
ssDNA patches are enriched in regions that undergo SHM
To determine whether ssDNA detected on chromatinized 
substrates was more abundant in regions undergoing SHM, 
we compared the frequency of consecutive converted dCs in 
the hypermutating V and the nonmutating C regions of the 
Ramos Ig heavy chain (IgH) gene (Fig. 2 A) (37). To account 
for the fact that there is only one functional heavy chain V 
region allele, and there are two C region alleles of which only 
one is transcribed in Ramos cells, we divided the number of 
converted dCs in patches of diff  erent sizes in the V region by 
two and compared that to the frequency of such consecutive 
converted dCs in the C region. Even   using this more strin-
gent comparison, we found signifi  cantly more patches with 
three or more consecutive converted dCs in the V than in 
the C region (P = 0.0018 for the upper strand and P = 0.016 
for the lower strand) (Fig. 2 A). Patches of three or more 
consecutive converted C’s were present in 23% of the 286 
Ramos V   sequences analyzed, and most of these DNA mole-
cules bore one ssDNA patch. Such patches were not detected 
in any of 98 deproteinized genomic DNA sequences, nor 
in 209   sequences derived from untreated nuclei. The pres-
ence of these ssDNA patches in chromatinized, but not 
  deproteinized or untreated substrates suggests that patches of 
Table I.  Mutation frequencies of genes in Ramos cells
Gene Mutations Bases sequenced Mutation frequency
V 58 55104 1.05 × 10−3
C 4 22349 1.79 × 10−4
BCL6 1 15955 6.27 × 10−5
RNAP II 1 14792 6.76 × 10−5
MDM2 1 11836 8.45 × 10−5
CD27 2 12865 1.55 × 10−4
CDKN2C 0 10992 <9.10 × 10−5
CD4 1 10806 9.25 × 10−5
DNA was amplifi  ed from Ramos cells using the Pfu DNA polymerase, with the primers listed in Table S1.184  PATCHES OF SSDNA IN MUTATING V REGIONS | Ronai et al. 
ssDNA form in the V region chromatin as part of higher order 
  molecular complexes.
Next, we determined the frequency of ssDNA patches in 
another hypermutating gene, c-MYC. In Burkitt’s lymphoma 
cell lines, such as Ramos, one c-MYC allele is translocated to the 
IgH locus, and it is transcribed and undergoes SHM while the 
untranslocated allele is silent and does not mutate (40 and not 
depicted). We compared the same region of the two c-MYC 
  alleles with respect to the presence of patches of ssDNA with 
three or more bisulfi  te-accessible dCs and found that the trans-
located allele had signifi  cantly more patches of ssDNA than the 
untranslocated allele (Fig. 2 B). The fact that these c-MYC re-
gions have identical DNA sequences and signifi  cantly diff  erent 
ssDNA frequencies suggests that formation of ssDNA patches 
does not depend solely on the primary DNA sequence.
Several genes are highly transcribed but do not undergo 
SHM in Ramos (Table I) and other hypermutating cells (35). 
We tested whether patches of ssDNA were present in these 
genes in Ramos cells by analyzing regions >100 bp but 
<1 kb downstream of the promoter, which is the region that 
contains mutations in genes undergoing SHM (1). As shown 
in Fig. 2 C, BCL-6, RNAP II, TATA-binding protein (TBP), 
MDM2, CD27, and CDK2NC, as well as CD4, which is 
  expressed in Jurkat, but not Ramos cells, had a signifi  cantly 
lower frequency of ssDNA patches than the Ig V region. 
These results support the idea that bisulfi  te-accessible patches 
of ssDNA are present at a higher abundance in genes that 
  undergo SHM.
Characterization of ssDNA patches in the Ramos V region
We measured the average size of ssDNA patches in the 
  Ramos V region and found their median length to be around 11 
bases, although there was a wider distribution for upper strand 
patches (Fig. 3 A). We were able to detect more patches on 
Figure 2.  Comparison of ssDNA frequencies in hypermutating and 
nonmutating regions. (A) The frequency of consecutive converted dCs 
was compared between the hypermutating VH (V) and the nonmutating 
Cμ (C) regions (depicted above the graph) in the IgH gene in Ramos 
cells. Single-stranded dCs were classifi  ed according to the number of 
consecutive converted dCs (for the upper strand) or dGs (for the lower 
strand). Values above or below pairs of bars indicate p-values. The 
V region frequencies were divided by two to account for the fact that 
there are half as many alleles of the functional V region compared 
with C, but one of the two C region alleles is not transcribed. (B) The 
frequency of ssDNA patches with three or more consecutive converted 
dCs was compared for the two c-MYC alleles. One allele is translocated 
in the proximity of the IgH locus, is expressed, and undergoes SHM, 
whereas the untranslocated allele is transcriptionally silent. Numbers 
indicate p-values. (C) The frequency of ssDNA patches was measured 
for nonmutating genes in Ramos cells and compared with the frequency 
of ssDNA in patches in the V and C region, and only patches with four 
or more consecutive converted Cs were taken into account for these 
calculations. Although BCL6 mutates in some human cells (references 
12 and 72), it does not mutate in Ramos cells. No signifi  cant mutations 
were detected in any of these genes, except the V region (Table I). Sample 
sizes are indicated in Table S2. p-values indicate the signifi  cance of the 
difference in ssDNA frequency in the corresponding gene or region and 
the Ramos VH region.JEM VOL. 204, January 22, 2007  185
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the lower than on the upper DNA strand (Fig. 3 B). We were 
concerned that there might be even larger patches that would 
only have been detected if the dCs in the primers were con-
verted to dTs (or dGs were converted to dAs) to allow the 
amplifi   cation of very long putative bisulfi  te-converted 
  sequences (18). However, we did not detect patches of ssDNA 
when we used various combinations of mutated and wild-
type primers in which all or only 50% of dCs and dGs were 
converted to dTs and dAs, respectively, to allow them to 
amplify such potential long stretches of bisulfi  te-converted 
DNA (18 and not depicted). These primers were effi   cient at 
amplifying bisulfi   te-converted genomic DNA, which was 
  artifi  cially rendered single stranded through boiling. Thus, 
most single-stranded patches in the Ramos V region are short 
(Fig. 3 B).
SHM-generated mutations occur in vivo on both the 
coding and noncoding strands (41, 42), and, likewise, ssDNA 
patches are located on both DNA strands (Fig. 3 B). Assum-
ing that most clusters of dCs form within an  11-nucleotide 
interval (Fig. 3 A), we calculated that diff  erent subregions 
within V have diff  erent “relative potentials” to allow detec-
tion of bisulfi  te-accessible ssDNA patches of three or more 
consecutive nucleotides for each dC residue (Fig. 3 C). We 
found that ssDNA patches (Fig. 3 B) do not always form 
preferentially in regions that had a suffi   cient abundance of 
dCs (Fig. 3, B and C) and thus are not due solely to the primary 
nucleic acid sequence, in particular portions of the V region.
Transcription is required for the formation of ssDNA
Active transcription is necessary for SHM in vivo (11, 43), and 
the rate of transcription has been correlated with the extent of 
SHM (28, 44). It has been hypothesized that the source of 
  ssDNA might be the nontemplate strand of transcription bub-
bles (4, 9) or supercoiled DNA at the end of transcription 
bubbles (25). We observed that the median length of ssDNA 
patches in the V regions analyzed was  11 bases (Fig. 3 A), a size 
similar to that of transcription bubbles (45). To determine 
whether transcription by RNA polymerase II (RNAP II) 
was coupled with the formation of ssDNA in regions subject 
to SHM, we incubated Ramos cells with α-amanitin, an 
  inhibitor of RNAP II, and measured the frequency of 
  ssDNA patches in treated and untreated cells. Incubation with 
α-amanitin signifi  cantly decreased the frequency of patches in 
Figure 3.  Characterization of ssDNA patches in the Ramos 
V region. (A) The average length of all patches in A was calculated as 
described in Materials and methods. (B) ssDNA patches found in the 
 Ramos  V region (depicted at the top; L-leader exon, CDR1-three comple-
mentarity-determining regions in the V exon) were plotted for the upper 
(black) and lower (white) strands. Each box indicates a unique patch in 
individual Ramos cells. The TATA box is  60 bp upstream of the start of 
L. Because only single strandness of dCs could be determined using 
bisulfi  te, the minimum (boxes) and the maximum sizes (horizontal lines 
crossing boxes), as exemplifi  ed in Fig. 1 E, could be determined. (C) The 
graph shows, on the vertical axis, the relative potential to form ssDNA 
patches of three or more consecutive nucleotides for each dC residue in 
the analyzed V region on the horizontal axis. This potential was calculated 
as the ability of each dC to be found in a theoretical 11-base patch. 
Figure 4.  The role of transcription in ssDNA formation. (A) Ramos 
cells were treated with α-amanitin as described in Materials and methods, 
and then used to determine the frequency of ssDNA patches in the IgH V 
region. Numbers indicate p-values. (B) Relative binding to RNAP II by pol 
II-ChIP (reference 71). Bars indicate the average of three experiments, and 
error bars indicate the standard deviation of these measurements. 
(C) Sense (fi  lled line) or antisense (dotted line) RNA transcripts were reverse-
transcribed using strand-specifi  c primers (arrows) containing a Tag 
sequence (gray) on the 5′ end of the RT primer. Primer sequences are 
shown in Table S1. cDNA was amplifi  ed with the Tag PCR primer (gray 
box) in combination with either the forward primer (fi  lled arrow) or the 
reverse (dotted arrow) VH-specifi  c primer, and the products were run on 
an agarose gel and strained with ethydium bromide (D). RT-PCR products, 
expected to be 112 bp long, were sequenced and determined to contain 
the Ramos VH region and the Tag sequence on the 3′ end (lane 3) or on 
the 5′ end (lane 10).186  PATCHES OF SSDNA IN MUTATING V REGIONS | Ronai et al. 
the V region (Fig. 4 A), suggesting that RNAP II–mediated 
transcription is necessary for the formation of the ssDNA 
patches that we found.
If transcription is necessary for the formation of ssDNA, 
it is possible that the frequency of ssDNA patches is directly 
proportional to the rate of RNAP II–mediated transcription. 
Indeed, we observed patches on the transcribed, but not 
  untranscribed c-MYC allele (Fig. 2 B). It is possible that the 
reason why there is more ssDNA in the V than in the C region 
is a higher level of RNAP II density in the V than in the 
C region. To test this possibility, we immunoprecipitated 
RNAP II–bound DNA and amplifi  ed it with primers spe-
cifi  c for the V and C regions. (In Fig. 4 B, we normalized the 
amount of immunoprecipitated DNA by the amount of 
  input DNA, and thus our analysis is independent of the effi   -
ciency of V- and C-specifi  c PCR primers). The abundance 
of RNAP II in the C region was half that in the V region, 
but signifi  cantly more than in the silent CD4 gene. Although 
we observe a 50% diff  erence in the density of RNAP II, if there 
is no RNAP II bound to the Cμ allele rearranged to c-MYC 
there would be no diff  erence between the density of RNAP II 
in the V and C regions. Thus, although transcription is required 
for the formation of ssDNA, it is not suffi   cient to explain 
the increase in ssDNA patches, but passage of, or pausing of, 
RNAP II in a particular DNA region (11) could be a con-
tributing factor for the formation of protein–DNA complexes 
containing ssDNA.
It has been assumed that only the template strand of 
  protein-coding genes is transcribed. In vitro and in bacteria, 
the nontranscribed strand of various target genes accumulated 
more AID-induced mutations, perhaps because the tran-
scribed strand is protected by RNA polymerase (6, 46). 
However, in vivo both strands are targeted for AID muta-
tions (41). Both the coding and the noncoding strands are 
transcribed in a great number of genes in the genome (47), 
and antisense transcription in the IgH locus occurs in a regu-
lated manner in early B cell development (48), although anti-
sense transcription has not been reported in V regions or in 
centroblast cells. If the nontranscribed strand of RNAP II 
transcription bubbles is the source of ssDNA during SHM 
and ssDNA was found on both strands (Fig. 3 B), the V 
  region should be transcribed in both orientations. To test this 
possibility, we used a method, outlined in Fig. 4 C, to specif-
ically amplify RNA derived from the coding and noncoding 
strands. To ensure that the RT-PCR products are derived by 
amplifying cDNA and not DNA, we designed the RT prim-
ers to contain a unique sequence that is not present in the 
DNA (49). As shown in Fig. 4 D, this procedure allowed us 
to identify both sense and antisense RNA transcripts derived 
from the V region. Analysis of the relative abundance of sense 
and antisense RNAs revealed that the antisense transcript 
is present at approximately eightfold lower levels than the 
sense V region transcript in Ramos cells (Fig. S4, available 
at http://www.jem.org/cgi/content/full/jem.20062032/DC1). 
However, nonsense-mediated RNA decay or other mecha-
nisms might render the antisense transcript more unstable 
than the sense transcript, so a quantitative comparison of 
the levels of the two transcripts may not refl  ect their rate 
of transcription.
Because replication forks have regions of ssDNA, we 
  examined whether or not ssDNA patches are found exclu-
sively in the S phase. It has been reported that mutations 
arise in the G1/S phase of the cell cycle (50), and double-
strand breaks that are thought to be a byproduct of SHM 
  accumulate in S/G2 (51). We fractionated cells by elutria-
tion, treated   individual fractions with bisulfi  te, and deter-
mined the frequency of ssDNA in both the upper and lower 
strands. As shown in Fig. S5 (available at http://www.jem
.org/cgi/content/full/jem.20062032/DC1), patches could 
be detected throughout the cell cycle, and upper strand 
ssDNA patches accumulated in the G1/S, S/G2, and G2 
phases, whereas lower strand patches were most abundant in 
G1/S. Thus, we found that, although ssDNA could be detected 
throughout the cell cycle, the extent of coding and non-
coding strand ssDNA varied throughout the cell cycle and did 
not occur exclusively in conjunction with replication forks.
ssDNA patches can be detected in wild-type 
and AID−/− mice
Because all of the studies described above were performed 
using B cell lines, we also examined the V regions in B cells 
from mice immunized with 4-hydroxy-3-nitrophenyl acetyl 
(NP) coupled to chicken γ globulin (CGG; Fig. 5 A) (52). As 
in human B cell lines, there were ssDNA patches on both 
strands of the rearranged V region of mouse splenocytes, but 
not in the Cγ1 region in splenocytes from immunized mice 
(not depicted). These patches were similar in size to the ones 
found in human cell lines (Fig. 3). Due to the need to analyze 
a very large number of cells for the bisulfi  te assay, we were 
Figure 5.  AID is dispensable for the formation of ssDNA in hyper-
mutating regions. (A) Splenocytes from mice immunized with NP were 
isolated and fixed, and then treated with sodium bisulfite. DNA was 
 purifi  ed, and the rearranged V186.2-D-JH region was amplifi  ed by PCR 
(references 52 and 73). ssDNA patches (black for the upper strand, 
white for the lower strand) are shown for each animal. Boxes indicate the 
minimum range of ssDNA patches, whereas lines indicate the maximum 
length. (B) ssDNA patches in the V regions of splenocytes from AID-defi  cient 
(AICDA−/−) and AICDA+/+ littermate control mice, analyzed as in A.JEM VOL. 204, January 22, 2007  187
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unable to separate naive and GC lymphocytes, and were thus 
unable to determine the frequency of ssDNA patches in pri-
mary cells at diff  erent stages of diff  erentiation.
We then examined IgH V regions in AID-defi  cient 
(AICDA−/−) mice (3) and found ssDNA in both AICDA+/+ 
and AICDA−/− mice (Fig. 5 B). Likewise, the frequency of 
ssDNA patches was similar in two Ramos cell subclones, one 
of which had a fi  vefold decrease in AID mRNA expression 
relative to the other and did not undergo detectable levels of 
V region mutations (Fig. S6, available at http://www.jem
.org/cgi/content/full/jem.20062032/DC1) (38). These fi  nd-
ings suggest that ssDNA patches form independently of AID 
in V region genes.
DISCUSSION
During CSR, AID deaminates ssDNA in the context of 
DNA–RNA complexes called R loops, which form in switch 
recombination sequences. We sought to determine the origin 
of the ssDNA substrate of AID during SHM in V regions. 
Unlike switch recombination sequences, hypermutating V 
regions do not form R loops. By devising an assay to assess 
the presence of ssDNA in the context of chromatin, we have 
shown that V and some other hypermutating regions of cul-
tured and primary B cell nuclei are enriched in chromatin-
  associated ssDNA. Unlike GC-rich switch regions that form R 
loops in which ssDNA is stabilized by DNA–RNA hybrids 
(18, 21), IgV regions do not form R loops. Indeed, we failed 
to identify ssDNA in deproteinized DNA from IgV regions 
using a protocol similar to that used to detect R loops in 
switch regions from B cell chromosomes (Fig. 1 C). Instead, 
we were able to detect ssDNA in the V region of B cell DNA 
when the binding of DNA-associated proteins was preserved 
(Fig. 1 D), whereas the identifi  cation of ssDNA was lost with 
pretreatment with proteinase K (Fig. 1 F). It is possible that 
unstable DNA–RNA hybrids also contribute to the forma-
tion of these ssDNA patches. To test this possibility, we pre-
treated fi  xed nuclei, as well as fi  xed chromatin fi  bers detached 
from the nuclear membrane, with RNaseH but were unable 
to detect a decrease in the frequency of ssDNA after treat-
ment (not depicted). However, this negative result may not 
be informative because RNaseH might not have gained full 
access to DNA–RNA hybrids in complexes of fi  xed nucleic 
acids and proteins. In addition to bisulfi  te, other chemicals, 
such as bromoacetaldehyde (53), permanganate (54), or 
  osmium tetroxide (55), could be used to detect ssDNA in cell 
nuclei. These assays nevertheless would have to be adapted to 
detect ssDNA in individual DNA molecules, as opposed to 
populations of molecules, because ssDNA patches appear 
to be relatively rare when detected using our bisulfi  te-
based assay.
Mutations occur on both strands in Ig V regions, start    -
ing   100 bp after the start of transcription, with a peak 
around 300 bases 3′ of the promoter (56–58). To determine 
whether ssDNA patches are distributed in a similar manner to 
mutations in the Ramos V region, we plotted the location of 
ssDNA patches along the IgH V region (Fig. 3 B) and found 
that they were distributed unevenly along both strands of the 
V region. Moreover, lower strand ssDNA patches accumu-
lated at higher levels starting  150 bases 3′ of the V pro-
moter, whereas upper strand patches accumulated  240 bases 
3′ of the V promoter, and both upper and lower strand 
patches peaked around 300 bases 3′ of the promoter. This 
distribution roughly corresponds to that of mutation accu-
mulation in Ig V regions (58). Bisulfi  te detection of ssDNA is 
limited to determining whether dCs, but not other bases, are 
single stranded. Using the relatively small number of patches 
that we have identifi  ed, we were unable to determine rigor-
ously whether hotspots of SHM (59) or other motifs were 
shared amongst various ssDNA regions. A program (60) pre-
viously used to detect potential secondary DNA structures in 
switch recombination sequences (61, 62) did not allow us to 
detect a correlation between predicted DNA secondary 
structures, such as loops in hairpin loops, and the location of 
ssDNA patches (not depicted).
Transcription is necessary for SHM, and the rate of tran-
scription is proportional to the rate of SHM (28, 44). Several 
observations support the view that transcription is required to 
create the ssDNA patches that we have observed. We found 
that blocking RNAP II–mediated transcription ablated the 
formation of ssDNA patches in the Ig V regions (Fig. 4 A), 
and ssDNA could not be detected in the silent cMYC allele or 
CD4 (Fig. 2, B and C). Moreover, the modal size of ssDNA 
patches was similar to that of transcription bubbles (Fig. 3 A). 
Finally, both the density of single-stranded regions and the 
RNAP II density were higher in the V than in the C region, 
perhaps refl  ecting a higher rate of transcription in the 5′ end 
of genes (63) or pausing (11) (Fig. 4 B). Both strands of the 
Ig V region were actively transcribed (Fig. 4 D), and sense 
and antisense transcripts have been found in the c-MYC 
gene in Burkitt’s lymphoma cells (64), providing a potential 
explanation for why ssDNA was found on both the template 
and the nontemplate strands. Our assay did not enable us 
to determine whether sense and antisense transcription 
  occurred simultaneously in the same DNA molecule. If they 
did, it is possible that the sense and antisense transcription 
complexes may collide, as documented in budding yeast (65), 
thus stabilizing ssDNA on opposite strands. Alternatively, the 
source of stable ssDNA could be the collision of the RNAP 
II complex with other DNA-binding molecules such as 
topoisomerase I (66).
Evidence from other studies suggests that DNA in V 
  regions that undergo SHM is subjected to single-strand and 
double-strand breaks (67–69), which could refl  ect  labile 
DNA structures that are subject to cleavage. These breaks, 
however, could not be detected with the bisulfi  te assay we 
used in this study, which is based on PCR amplifi  cation of 
intact V region molecules, although the ssDNA patches we 
observe could be DNA molecules immediately after religa-
tion. Collectively, these results suggest that ssDNA patches 
form in conjunction with the transcription complex. How-
ever, transcription alone is not suffi   cient to generate SHM-
specifi  c ssDNA because the diff  erence in the frequency of 188  PATCHES OF SSDNA IN MUTATING V REGIONS | Ronai et al. 
ssDNA patches between the V and C regions cannot be 
  explained solely by the diff  erence in RNAP II density between 
the two regions, and there are other transcribed genes in B 
cells that do not have ssDNA patches and do not undergo 
SHM (Fig. 2 C).
We also found ssDNA in primary cells that were under-
going SHM (Fig. 5) independently of the presence of AID 
(Fig. 5 B). Histone hyperacetylation in hypermutating   regions 
and double-strand breaks that have been associated with 
SHM are also independent of the presence of AID (30, 70), 
whereas histone phosphorylation and histone hyperacety-
lation in switch regions occurred less effi   ciently or not at all 
in AID-defi   cient cells (33, 34). It is possible that ssDNA 
patches form before the expression of AID and thus represent 
an early step in targeting SHM to specifi  c DNA regions.
We conclude that the ssDNA patches are generated as 
part of protein–DNA complexes whose formation requires 
transcription but not AID. We propose that chromatin-
  associated ssDNA serves as a molecular nidus to which AID 
as well as other proteins subsequently bind and mediate the 
SHM process. Bisulfi  te sequencing of chromatinized DNA 
could thus be used to search for other potential targets of 
SHM in the genome and to uncover the mechanism whereby 
SHM is targeted in healthy and cancerous B cells.
MATERIALS AND METHODS
Cell lines and mice. The Ramos cell lines have been described (38). Jurkat 
cells were provided by T. Graf (Albert Einstein College of Medicine). 
AICDA knockout mice (3) were provided by T. Honjo (Kyoto University, 
Kyoto, Japan). Both wild-type and knockout mice were immunized intra-
peritoneally at 2–3 mo of age with 23NP-CGG (BioSearch Technologies) in 
alum (Pierce Chemical Co.). Mice were immunized on day zero with 100 
mg NP-CGG, then at day 14 and again on day 15 with 100 mg NP-CGG 
in alum. Splenocytes were analyzed 1 wk after the secondary immunization. 
All of the mouse studies were approved by the Albert Einstein Animal 
Use Committee.
Bisulfi  te treatment of cells. 107 cells were fi  xed at room temperature with 
1% formaldehyde for 5 min. The reaction was stopped with glycine to a fi  nal 
concentration of 125 mM. Nuclei were isolated and permeabilized by incu-
bating cells in each of the following buff  ers for 20 min: buff  er A (10 mM 
Tris-HCl, pH 8, 10 mM EDTA, pH 8, 0.5 mM EGTA, pH 8, 0.25% Triton 
X-100) and buff  er B (0.2 M NaCl, 10 mM Tris-HCl, pH 8, 1 mM EDTA, 
0.5 mM EGTA), and then resuspended in buff  er C (0.3 M NaCl, 40 mM 
Tris-HCl, 4 mM EDTA, 1% Triton X-100). All buff  ers contained complete 
protease inhibitors (Roche). Nuclei or purifi  ed genomic DNA was incu-
bated in a fresh solution containing 5 M sodium bisulfi  te and 20 mM hydro-
quinone and incubated at 37°C for 18 h. “Chromatinized” DNA was treated 
as described above, and “untreated” controls were handled similarly, except 
that no bisulfi  te was added during the fi  nal incubation. The cross-link was 
reversed, and DNA was purifi  ed with the addition of proteinase K (Roche) 
to a fi  nal concentration of 0.58 mg/ml by incubation at 55°C for 2 h, and 
then at 65°C overnight. DNA was purifi  ed using a Wizard genomic purifi  -
cation kit (Promega), and then disulphonated by incubation for 15 min with 
NaOH to a fi  nal concentration of 0.3 M, neutralized with ammonium ace-
tate to a fi  nal concentration of 3 M, and purifi  ed by ethanol precipitation. In 
some cases, nuclei were pretreated overnight before incubation with bisulfi  te 
with 6 U proteinase K or 1 U RNaseH (Roche) per 106 cells. “Deproteinized” 
DNA was purifi  ed as genomic DNA, and then treated with bisulfi  te. 
  Chromatinized, untreated, or deproteinized DNA was amplifi  ed by PCR 
using primers listed in the Table S1 (available at http://www.jem.org/cgi/
content/full/jem.20062032/DC1) using Taq polymerase, which is able to 
copy deoxyuridine, cloned in TOPO TA vectors (Invitrogen), and 
sequenced with the M13 reverse primer. For mutation analysis, controls that 
were not treated with bisulfi  te were amplifi  ed with Pfu Turbo polymerase 
(Stratagene), cloned using the Zero Blunt PCR cloning system (Invitrogen), 
and sequenced. Mouse splenocytes were dislocated from spleens using the 
balloon method and immediately fi  xed, permeabilized, and treated with 
  bisulfi  te, as described above.
Analysis of transcription. Cells were treated with 0.25 μg/ml α-amanitin 
(Sigma-Aldrich) for 24 h. RNAP II chromatin immunoprecipitation was 
performed as described previously (71). In brief, 108 cells were cross-linked 
with 1% formaldehyde for 10 min at room temperature, and the reaction was 
quenched by the addition of glycine to a fi  nal concentration of 0.125 M, and 
then washed three times with PBS. Cells were placed in lysis buff  er (1% 
SDS, 10 mM EDTA, 50 mM Tris-HCl, pH 8.0) and sonicated on ice in 
a Sonic Dismembrator (model 500; Fisher Scientifi  c) with pulses of 30 s and 
a rest of 1 min in between pulses for a total time of 12 minutes at 55% ampli-
tude to obtain an average DNA fragment length of 200 bp. The soluble 
chromatin fraction obtained after centrifugation was diluted 10 times and 
precleared with 30 μl/ml blocked protein A agarose beads (GE Healthcare). 
100 μl of precleared lysate was saved to determine the chromatin input. 
Chromatin immunoprecipitation was achieved by overnight incubation at 
4°C with 2 μg/ml anti–RNAP II (Santa Cruz Biotechnology, Inc.) or rabbit 
IgG anti-actin (Sigma-Aldrich). Controls immunoprecipitated with either 
anti-actin antibodies or no antibodies showed no detectable PCR product 
(unpublished data). Immunoprecipitated DNA was analyzed by real-time 
quantitative PCR using SYBRGreen (QIAGEN) and primers listed in Table 
S1. For strand-specifi  c RT-PCR, RNA was prepared using the RNAWiz 
  reagent (Ambion) according to the manufacturer’s specifi  cations. DNA was 
digested with DNaseI (Worthington) for 30 min at 37°C. Strand-specifi  c RT 
was performed as described previously (48), except that RT primers contain 
the Tag sequence 5′C  A  G  G  T  C  A  T  G  G  T  G  G  C  G  A  3′ on the 5′ end. PCR was 
performed using the Tag primer and gene-specifi  c primers listed in Table S1.
Calculation of average length of ssDNA patches. The minimum 
length of ssDNA patches that contained more than three consecutive con-
verted dCs was determined by counting the distance, in nucleotides, 
between the furthest converted bases, including the intervening non-dC for 
the upper strand (or nondeoxyguanine for the lower strand). The maximum 
length of these patches was determined by counting the nucleotides between 
(and excluding) the nonconverted dCs to the 5′ and 3′ ends of the patch. 
The minimum and maximum lengths were determined separately for upper 
and lower strands, and the number of occurrences of each length was 
summed up and plotted.
Statistical analysis. ssDNA patches are defi  ned as stretches of DNA con-
taining bisulfi  te-modifi  ed dCs on either strand without any intervening un-
modifi  ed bases. Unless otherwise indicated, only patches longer than three 
consecutive C’s were taken into account. The frequency of ssDNA was cal-
culated as the ratio between the number of C’s in ssDNA patches and the 
total number of C’s sequenced. The number of modifi  ed and unmodifi  ed 
C’s between diff  erent sequences was compared using the two-tailed Chi-
squared test.
Online supplemental material. Fig. S1 shows the detection of ssDNA 
using sodium bisulfi  te. Fig. S2 shows the detection of ssDNA in R loops 
  using deproteinized and chromatinized DNA. Fig. S3 shows the detection of 
ssDNA in Ig-variable regions in human B cell lines. Fig. S4 depicts antisense 
transcripts in the Ramos V region, and Fig. S5 shows cell cycle distribution 
of ssDNA in Ramos cells. Fig. S6 is the ssDNA frequency in two Ramos 
cell subclones that diff  er in the amount of AID expression. Table S1 lists 
PCR and RT-PCR primers used in this study. Table S2 lists the sample 
size for bisulfi  te analysis. The online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20062032/DC1.JEM VOL. 204, January 22, 2007  189
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